Cstone Pharmaceuticals
Clinical trials sponsored by Cstone Pharmaceuticals, explained in plain language.
-
New hope for advanced liver cancer patients in major global trial
Disease control OngoingThis large, late-stage study is testing whether adding a new immunotherapy drug (nofazinlimab) to an existing cancer drug (lenvatinib) works better than the existing drug alone for people with advanced liver cancer who haven't had other drug treatments. The main goal is to see if…
Phase: PHASE3 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
New hope for Tough-to-Treat lung cancer patients
Disease control OngoingThis study is testing whether the drug lorlatinib can help control advanced lung cancer that has a specific genetic change called ROS1 and has worsened despite two prior standard treatments. It involves 70 patients in China who have already tried crizotinib and platinum chemother…
Phase: PHASE2 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC